JPI-289

· Jeil Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JPI-289, covering 2016-06-24 to 2019-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke [Phase 2]